Annalise Enterprise CTB is a cutting-edge, AI-powered decision-support solution designed for non-contrast CT brain (NCCTB) studies. Acting as a “second pair of eyes” for radiologists, it enhances diagnostic accuracy and efficiency by detecting up to 130 radiological findings, including conditions requiring rapid intervention. The solution is CE marked as a class IIb medical device and is available for clinical use in multiple regions including the EU, UK, Australia, and more.

Features

• Detection of 130 Findings: Covers a wide range of radiological conditions on NCCTB studies.
• Rapid Results: Findings are available in under 2 minutes.
• Worklist Prioritization: AI models analyze studies in RIS/PACS systems and prioritize cases based on urgency.
• Automated Draft Reporting: Generates editable draft reports integrated into routine workflows.
• Multiplanar Image Highlighting: Automatically marks suspected findings with pathology-appropriate settings.
• Trained on Extensive Data: Over 229,000 unique CTB studies annotated by 150+ consultant radiologists.
• Robust Annotation: More than 269 million CTB labels used to train the AI model.
• Integrated Viewer: Designed by clinicians for clinicians, with intuitive UI and fast access to results.

Benefits

• Improved Diagnostic Accuracy: Average 32% improvement across all findings.
• Efficiency Gains: 11% average improvement in reporting efficiency.
• Time Savings: 60% of clinicians report faster workflows.
• Enhanced Confidence: 9 out of 10 clinicians say it improves reporting accuracy.
• Better Patient Outcomes: Enables faster and more accurate decision-making.
• Clinician-Endorsed: Widely praised by radiologists for usability and impact on patient care.
• Global Availability: CE marked and available in Australia, New Zealand, EU, UK, India, Singapore, UAE, and more.